Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 140
Filtrar
Más filtros

Medicinas Complementárias
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Bull Exp Biol Med ; 171(2): 281-285, 2021 May.
Artículo en Inglés | MEDLINE | ID: mdl-34173919

RESUMEN

We used specific histochemical fluorescence-microscopic method of visualization of catecholamines to study adrenergic innervation of the thyroid gland tissue, blood vessels of the thyroid gland, cervical lymphatic vessel and lymph nodes in rats during correction of hypothyroidism with a bioactive formulation (Vozrozhdenie Plus balm with Potentilla alba L.). In experimental hypothyroidism, adrenergic innervation of the thyroid gland and the wall of the cervical lymph node, concentrated mainly along the arterial vessels and the cervical lymphatic vessel, retained its structural formations (plexuses and varicosities), but diffusion of catecholamines outside these formations was observed. Correction with the bioactive formulation restored of the contours of the nerve plexuses and varicosities and their brighter fluorescence in the thyroid gland and cervical lymphatic vessel and node. During correction of hypothyroidism with the bioactive formulation, reorganization of regional lymphatic vessels and nodes was more pronounced than reorganization of the thyroid gland.


Asunto(s)
Hipotiroidismo , Ganglios Linfáticos/patología , Vasos Linfáticos/patología , Glándula Tiroides/irrigación sanguínea , Glándula Tiroides/inervación , Fibras Adrenérgicas/efectos de los fármacos , Fibras Adrenérgicas/patología , Fibras Adrenérgicas/ultraestructura , Animales , Vasos Sanguíneos/diagnóstico por imagen , Vasos Sanguíneos/efectos de los fármacos , Vasos Sanguíneos/patología , Hipotiroidismo/diagnóstico por imagen , Hipotiroidismo/tratamiento farmacológico , Hipotiroidismo/patología , Ganglios Linfáticos/diagnóstico por imagen , Ganglios Linfáticos/efectos de los fármacos , Vasos Linfáticos/diagnóstico por imagen , Vasos Linfáticos/efectos de los fármacos , Masculino , Microscopía Fluorescente , Extractos Vegetales/farmacología , Extractos Vegetales/uso terapéutico , Yoduro de Potasio/farmacología , Yoduro de Potasio/uso terapéutico , Ratas , Glándula Tiroides/diagnóstico por imagen , Glándula Tiroides/efectos de los fármacos , Hormonas Tiroideas/farmacología , Hormonas Tiroideas/uso terapéutico
2.
J Immunol Res ; 2020: 2932696, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32884948

RESUMEN

OBJECTIVE: Hemophilic arthropathy is characterized by recurrent bleeding episodes in patients with hemophilia leading to irreversible joint degeneration. The involvement of CX3CL1 (fractalkine) and its receptor CX3CR1 was observed in the pathogenesis of numerous arthritis-associated diseases. Taking this into account, we have presented a study investigating the role of the CX3CL1/CX3XR1 axis in the course of hemophilic arthropathy, including the CX3CL1-dependent expression of CD56+, CD68+, and CD31+ cells along with evaluation of articular cartilage and synovial membrane morphology. METHODS: The study was carried out using cases (n = 20) of end-stage hemophilic arthropathy with a severe type of hemophilia A and control cases (n = 20) diagnosed with osteoarthritis. The biofluids including blood serum and synovial fluid were obtained intraoperatively for the evaluation of CX3CL1 using the ELISA test. Tissue specimens including articular cartilage and synovial membrane were similarly collected during surgery and stained immunohistologically using selected antibodies including anti-CX3CR1, anti-CD56, anti-CD68, and anti-CD31. Additionally, the analysis included the assessment of articular cartilage, synovial membrane, and blood vessel morphology. RESULTS: In our study, we have documented increased average concentration of CX3CL1 in the blood serum of the study group (7.16 ± 0.53 ng/ml) compared to the control group (5.85 ± 0.70 ng/ml) without statistically significant difference in synovial fluid concentration at the same time. We have observed an increased macrophage presence with more marked proliferation and fibrosis of the synovial membrane in the study group. Remaining results such as expression of CX3CR1 presence of NK cells and larger surface area of blood vessels within the synovial membrane were noted also without statistical significance. CONCLUSIONS: This study has demonstrated collective CX3CL1/CX3CR1 axis involvement in hemophilic arthropathy pathogenesis introducing new interesting diagnostics and a therapeutic target.


Asunto(s)
Artritis/etiología , Artritis/metabolismo , Receptor 1 de Quimiocinas CX3C/metabolismo , Quimiocina CX3CL1/metabolismo , Hemofilia A/complicaciones , Osteoartritis/etiología , Osteoartritis/metabolismo , Antígenos CD/metabolismo , Antígenos de Diferenciación Mielomonocítica/metabolismo , Artritis/diagnóstico , Biomarcadores , Vasos Sanguíneos/metabolismo , Vasos Sanguíneos/patología , Antígeno CD56/metabolismo , Receptor 1 de Quimiocinas CX3C/genética , Cartílago Articular/metabolismo , Cartílago Articular/patología , Estudios de Casos y Controles , Quimiocina CX3CL1/genética , Susceptibilidad a Enfermedades , Fibrosis , Expresión Génica , Humanos , Inmunohistoquímica , Osteoartritis/diagnóstico , Líquido Sinovial/metabolismo , Membrana Sinovial/metabolismo , Membrana Sinovial/patología
3.
Clin Exp Hypertens ; 42(7): 581-589, 2020 Oct 02.
Artículo en Inglés | MEDLINE | ID: mdl-32202168

RESUMEN

PURPOSE: The present work aimed to study the effect of aqueous extract of large cardamom (AELC) to prevent vascular remodeling and oxidative stress in Nω-Nitro-L-arginine methyl ester (L-NAME)-induced hypertension. METHOD: Male Wistar rats were administered with L-NAME 40 mg/kg/day for 28 days by oral gavage. The treatments included captopril (20 mg/kg/day) or AELC (100, 200 and 400 mg/kg/day) along with L-NAME administration. RESULTS: L-NAME treated rats showed high systolic, diastolic and mean arterial pressure, decreased nitric oxide level, increased level of malondialdehyde in plasma, heart, aorta and kidney, hypertrophy of the vascular wall and reduced vascular response to acetylcholine in phenylephrine-precontracted aorta. Treatment with AELC markedly reduced the blood pressure, restored the nitric oxide level, reduced the malondialdehyde level, alleviated the hypertrophy in L-NAME-induced hypertensive rats. Additionally, it also improved the vascular response to acetylcholine in phenylephrine pre-contracted aorta. CONCLUSION: In conclusion, our results demonstrate the preventive effect of AELC in L-NAME-induced hypertensive model, which is possibly related to antioxidant activities and restoration of nitric oxide level.


Asunto(s)
Elettaria , Hipertensión/fisiopatología , Estrés Oxidativo/efectos de los fármacos , Extractos Vegetales/farmacología , Remodelación Vascular/efectos de los fármacos , Acetilcolina/farmacología , Animales , Antihipertensivos/uso terapéutico , Antioxidantes/farmacología , Aorta/metabolismo , Presión Arterial/efectos de los fármacos , Vasos Sanguíneos/patología , Vasos Sanguíneos/fisiopatología , Captopril/uso terapéutico , Hipertensión/inducido químicamente , Hipertensión/complicaciones , Hipertrofia/etiología , Riñón/metabolismo , Masculino , Malondialdehído/metabolismo , Miocardio/metabolismo , NG-Nitroarginina Metil Éster , Óxido Nítrico/sangre , Ratas , Ratas Wistar , Vasodilatación/efectos de los fármacos , Vasodilatadores/farmacología
4.
J Therm Biol ; 78: 329-342, 2018 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-30509655

RESUMEN

Attaining a precise necrosis of tumor sparing normal tissue during carcinomas thermo-therapy via nominally invasive scheme like irradiation of laser is a recent challenge. In this study, a combined diffusion and convective energy equations were solved using COMSOL Multiphysics to predict the tissue thermal profile during laser assisted thermo-therapy with different tissue vascular networks. A comparative analysis between intratumoral and intravenous loading scheme of silica-gold nanoshells (AuNs) was also performed. AuNs cluster position and alignment was altered to achieve precise ablation of a large tumor with minimum damage to healthy tissue and improvement in necrosis in the vicinity of large blood vessels (LBV). A modified Beer-Lambert law and Arrhenius equation was applied to model laser heat propagation and to compute thermal damage respectively. Simulation results suggests the dominance of targeted nanostructure injection in cluster form over intravenous scheme in terms of precise control over spreading of necrotic zone due to selective laser dose delivery into the tumor. An effective tumor ablation, sparing normal tissue is best revealed for Type-A intratumoral scheme comparing Type-B and C as the reallocation of cluster position can help to achieve an irregular shaped necrotic zone. In addition a comparative analysis between dual-phase-lag (DPL) and classical Fourier approach within a tumor-blood inhomogeneous inner structure was made to access the effect of relaxation time onto biological thermal response. Numerical results show a difference in temperature profile between these two approaches during non-equilibrium condition i.e at the prior phases of laser heating and cooling whereas the results overlaps at higher instants. Since the DPL based bioheat conduction model can predict the inherent wave nature of the thermal front which is propagating at a finite speed. This study may improve the real clinical invasive schemes applied to ablate malignant tumor during hyperthermia treatment.


Asunto(s)
Vasos Sanguíneos/patología , Hipertermia Inducida/métodos , Nanopartículas del Metal/uso terapéutico , Modelos Teóricos , Neoplasias/terapia , Fototerapia/métodos , Oro/química , Humanos , Nanopartículas del Metal/química , Necrosis , Dióxido de Silicio/química
6.
J Immunol Res ; 2018: 9671919, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-30211234

RESUMEN

Excessive ethanol consumption causes adverse effects and contributes to organ dysfunction. Ethanol metabolism triggers oxidative stress, altered immune function, and gut dysbiosis. The gut microbiome is known to contribute to the maintenance of intestinal homeostasis, and disturbances are associated with pathology. A consequence of gut dysbiosis is also alterations in its metabolic and fermentation byproducts. The gut microbiota ferments undigested dietary polysaccharides to yield short-chain fatty acids, predominantly acetate, propionate, and butyrate. Butyrate has many biological mechanisms of action including anti-inflammatory and immunoprotective effects, and its depletion is associated with intestinal injury. We previously showed that butyrate protects gut-liver injury during ethanol exposure. While the intestine is the largest immune organ in the body, little is known regarding the effects of ethanol on intestinal immune function. This work is aimed at investigating the effects of butyrate supplementation, in the form of the structured triglyceride tributyrin, on intestinal innate immune responses and oxidative stress following chronic-binge ethanol exposure in mice. Our work suggests that tributyrin supplementation preserved immune responses and reduced oxidative stress in the proximal colon during chronic-binge ethanol exposure. Our results also indicate a possible involvement of tributyrin in maintaining the integrity of intestinal villi vasculature disrupted by chronic-binge ethanol exposure.


Asunto(s)
Consumo Excesivo de Bebidas Alcohólicas/dietoterapia , Vasos Sanguíneos/patología , Colon/efectos de los fármacos , Disbiosis/dietoterapia , Etanol/administración & dosificación , Intestinos/inmunología , Triglicéridos/uso terapéutico , Consumo de Bebidas Alcohólicas/efectos adversos , Animales , Consumo Excesivo de Bebidas Alcohólicas/complicaciones , Colon/patología , Suplementos Dietéticos , Modelos Animales de Enfermedad , Disbiosis/etiología , Etanol/efectos adversos , Femenino , Microbioma Gastrointestinal/efectos de los fármacos , Humanos , Inmunidad Innata/efectos de los fármacos , Intestinos/irrigación sanguínea , Intestinos/efectos de los fármacos , Ratones , Ratones Endogámicos C57BL , Estrés Oxidativo/efectos de los fármacos
7.
Biomed Pharmacother ; 108: 232-243, 2018 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-30219681

RESUMEN

The present study evaluated the effects of acute treatment with silymarin, an extract that is obtained from Silybum marianum, on angiogenesis, oxidative stress, and inflammation in normoglycemic and diabetic mice. Diabetes was induced by streptozotocin (80 mg/kg, intraperitoneal) in male Swiss mice, 6 weeks of age. A polyether-polyurethane sponge was surgically implanted in the back of the mice as a model of healing in both diabetic and normoglycemic animals that were treated with oral silymarin or water for 10 days. The pancreas, liver, kidneys, blood, and sponges were collected and analyzed. Diabetes led to impairments of antioxidant defenses, reflected by a reduction of pancreatic superoxide dismutase and hepatic and renal catalase and an increase in pancreatic lipoperoxidation. An inflammatory process was observed in diabetic mice, reflected by an increase in pancreatic tumor necrosis factor α (TNF-α) and the infiltration of inflammatory cells in islets. The number of vessels was lower in the implanted sponges in diabetic mice. Silymarin treatment attenuated this damage, restoring antioxidant enzymes and reducing pancreatic TNF-α and inflammatory infiltration. However, silymarin treatment did not restore angiogenesis or glycemia. In conclusion, treatment with silymarin red uced oxidative stress and inflammation that were induced in the model of streptozotocin-induced diabetes in several organs, without apparent toxicity. Silymarin may be a promising drug for controlling diabetic complications.


Asunto(s)
Diabetes Mellitus Experimental/tratamiento farmacológico , Diabetes Mellitus Experimental/patología , Neovascularización Fisiológica/efectos de los fármacos , Estrés Oxidativo/efectos de los fármacos , Silimarina/uso terapéutico , Animales , Vasos Sanguíneos/efectos de los fármacos , Vasos Sanguíneos/patología , Peso Corporal/efectos de los fármacos , Colágeno/metabolismo , Diabetes Mellitus Experimental/sangre , Depuradores de Radicales Libres/farmacología , Hiperglucemia/sangre , Hiperglucemia/complicaciones , Inflamación/patología , Riñón/efectos de los fármacos , Riñón/patología , Hígado/efectos de los fármacos , Hígado/patología , Masculino , Ratones , Mitocondrias/efectos de los fármacos , Mitocondrias/metabolismo , Páncreas/efectos de los fármacos , Páncreas/metabolismo , Páncreas/patología , Silimarina/farmacología
8.
Transpl Immunol ; 50: 15-25, 2018 10.
Artículo en Inglés | MEDLINE | ID: mdl-29885441

RESUMEN

BACKGROUND: Chronic rejection of transplanted organs is a major obstacle in organ transplantation. The main symptoms of chronic rejection are vessel occlusion and tissue fibrosis. Macrophages play a crucial role in chronic rejection. We showed previously that RhoA deletion or RhoA/Rock inhibition using Y27632 inhibitor reorganizes macrophage actin cytoskeleton, prevents macrophage movement to the cardiac allografts, and abrogates chronic rejection in rodent models. Although besides Y27632 there are other RhoA/ROCK inhibitors available commercially, their efficacy in inhibition of chronic rejection remains unknown. METHODS: We screened four RhoA/Rock inhibitors for their ability to inhibit chronic rejection of BALB/c [H-2d] mouse cardiac allografts heterotopically transplanted into C57BL/6 [H-2b] recipients. We also tested the effect of inhibitors on macrophages in vitro. RESULTS: We found that out of four tested compounds, the Fasudil and Azaindole, inhibited vessel occlusion, tissue fibrosis, decreased M2 macrophage infiltration and abrogated chronic rejection of mouse cardiac allografts. The remaining inhibitors, SAR-407899 and SLX-2119, decreased only tissue fibrosis, and were ineffective or only slightly effective in inhibiting vessel occlusion. We also found that Azaindole and Fasudil affected actin cytoskeleton and protein expression in mouse peritoneal macrophages CONCLUSION: Results of these studies might help in development of anti-chronic rejection therapy for clinical use.


Asunto(s)
Vasos Sanguíneos/efectos de los fármacos , Rechazo de Injerto/tratamiento farmacológico , Trasplante de Corazón , Inmunosupresores/uso terapéutico , Macrófagos/efectos de los fármacos , Inhibidores de Proteínas Quinasas/uso terapéutico , Animales , Vasos Sanguíneos/patología , Células Cultivadas , Enfermedad Crónica , Modelos Animales de Enfermedad , Evaluación Preclínica de Medicamentos , Antígenos de Histocompatibilidad/inmunología , Humanos , Isoantígenos/inmunología , Macrófagos/patología , Ratones , Ratones Endogámicos BALB C , Ratones Endogámicos C57BL , Transducción de Señal , Trasplante Homólogo , Quinasas Asociadas a rho/antagonistas & inhibidores , Quinasas Asociadas a rho/metabolismo , Proteína de Unión al GTP rhoA/antagonistas & inhibidores , Proteína de Unión al GTP rhoA/metabolismo
9.
Pflugers Arch ; 470(6): 883-895, 2018 06.
Artículo en Inglés | MEDLINE | ID: mdl-29500668

RESUMEN

Elevated plasma levels of the hormone vasopressin have been implicated in the pathogenesis of some forms of hypertension. Hypothalamic paraventricular and supraoptic nuclei neurons regulate vasopressin secretion into the circulation. Vasopressin neuron activity is elevated by day 7 in the development of angiotensin II-dependent hypertension in Cyp1a1-Ren2 rats. While microglial activation and blood-brain barrier (BBB) breakdown contribute to the maintenance of well-established hypertension, it is not known whether these mechanisms contribute to the early onset of hypertension. Hence, we aimed to determine whether microglia are activated and/or the BBB is compromised during the onset of hypertension. Here, we used the Cyp1a1-Ren2 rat model of hypertension and showed that ionised calcium-binding adapter molecule 1 staining of microglia does not change in the paraventricular and supraoptic nuclei on day 7 (early onset) and day 28 (well established) of hypertension, compared to the normotensive control. Endothelial transferrin receptor staining, which stains endothelia and reflects blood vessel density, was also unchanged at day 7, but was reduced at day 28, suggesting that breakdown of the BBB begins between day 7 and day 28 in the development of hypertension. Hence, this study does not support the idea that microglial activation or BBB disruption contribute to the onset of angiotensin II-dependent hypertension in Cyp1a1-Ren2 rats, although BBB disruption might contribute to the progression from the early onset to well-established hypertension.


Asunto(s)
Angiotensina II/metabolismo , Vasos Sanguíneos/patología , Hipertensión/etiología , Microglía/metabolismo , Animales , Vasos Sanguíneos/metabolismo , Barrera Hematoencefálica/metabolismo , Barrera Hematoencefálica/patología , Proteínas de Unión al Calcio/genética , Proteínas de Unión al Calcio/metabolismo , Citocromo P-450 CYP1A1/genética , Citocromo P-450 CYP1A1/metabolismo , Hipotálamo/citología , Hipotálamo/metabolismo , Masculino , Proteínas de Microfilamentos/genética , Proteínas de Microfilamentos/metabolismo , Ratas , Renina/genética , Renina/metabolismo
10.
Neurotoxicology ; 65: 98-110, 2018 03.
Artículo en Inglés | MEDLINE | ID: mdl-29427613

RESUMEN

Thiamine/vitamin B1 deficiency can lead to behavioral changes and neurotoxicity in humans. This may due in part to vascular damage, neuroinflammation and neuronal degeneration in the diencephalon, which is seen in animal models of pyrithiamine-enhanced thiamine deficiency. However, the time course of the progression of these changes in the animal models has been poorly characterized. Therefore, in this study, the progression of: 1) activated microglial association with vasculature; 2) neurodegeneration; and 3) any vascular leakage in the forebrain during the progress of thiamine deficiency were determined. A thiamine deficient diet along with 0.25 mg/kg/d of pyrithiamine was used as the mouse model. Vasculature was identified with Cd31 and microglia with Cd11b and Iba1 immunoreactivity. Neurodegeneration was determined by FJc labeling. The first sign of activated microglia within the thalamic nuclei were detected after 8 d of thiamine deficiency, and by 9 d activated microglia associated primarily with vasculature were clearly present but only in thalamus. At the 8 d time point neurodegeneration was not present in thalamus. However at 9 d, the first signs of neurodegeneration (FJc + neurons) were seen in most animals. Over 80% of the microglia were activated at 10 d but almost exclusively in the thalamus and the number of degenerating neurons was less than 10% of the activated microglia. At 10 d, there were sporadic minor changes in IgG presence in thalamus indicating minor vascular leakage. Dizocilpine (0.2-0.4 mg/kg) or phenobarbital (10-20 mg/kg) was administered to groups of mice from day 8 through day 10 to block neurodegeneration but neither did. In summary, activated microglia start to surround vasculature 1-2 d prior to the start of neurodegeneration. This response may be a means of controlling or repairing vascular damage and leakage. Glutamate excitotoxicity and vascular leakage likely only play a minor role in the early neurodegeneration resulting from thiamine deficiency. However, failure of dysfunctional vasculature endothelium to supply sufficient nutrients to neurons could be contributing to the neurodegeneration.


Asunto(s)
Vasos Sanguíneos/patología , Microglía/metabolismo , Degeneración Nerviosa/patología , Tálamo/metabolismo , Tálamo/patología , Deficiencia de Tiamina/metabolismo , Deficiencia de Tiamina/patología , Animales , Antígeno CD11b/metabolismo , Proteínas de Unión al Calcio/metabolismo , Dieta , Maleato de Dizocilpina/farmacología , Femenino , Ratones , Proteínas de Microfilamentos/metabolismo , Degeneración Nerviosa/prevención & control , Fenobarbital/farmacología , Piritiamina , Deficiencia de Tiamina/inducido químicamente , Factores de Tiempo
11.
Eur J Surg Oncol ; 44(5): 600-606, 2018 05.
Artículo en Inglés | MEDLINE | ID: mdl-29454557

RESUMEN

BACKGROUND: The status of serosal invasion is often discordance between pathological and intraoperative evaluation. Our study sought to develop a risk-scoring system (RSS) to predict the probability of pT4a for macroscopic serosal invasion (MSI) positive patients and reevaluate the serosal invasion status. PATIENTS AND METHODS: A total of 1301 pT3/pT4a gastric cancer patients with curative surgery were reviewed. We constructed the RSS to predict the probability of pT4a and assigned MSI-positive patients into different risk groups based on the risk scores. The prognostic significance of these risk groups was also evaluated. RESULTS: Univariate and multivariate analyses identified that tumor location, Lauren type, Borrmann type, tumor size, lymphovascular invasion and pN stage were risk factors related to pT4a. Survival analyses showed that pT3 MSI-positive patients in high-risk group had similar survival with pT4a patients. We incorporated these two groups into one stage and proposed a novel revised-T stage. Two-step multivariate analyses indicated that the revised-T stage showed better prediction ability for prognosis and peritoneal recurrence assessment than original pT stage and MSI status. CONCLUSIONS: In our present study, we developed a RSS to predict the probability of pT4a for MSI-positive patients. Based on our RSS, we proposed a treatment algorithm to reevaluate the tumor invasion for MSI-positive patients in clinical practice. Future studies should include other preoperative predictors to improve the clinical utility of our model.


Asunto(s)
Neoplasias Peritoneales/epidemiología , Peritoneo/patología , Neoplasias Gástricas/patología , Vasos Sanguíneos/patología , Quimioterapia Adyuvante , Femenino , Gastrectomía , Humanos , Hipertermia Inducida , Infusiones Parenterales , Escisión del Ganglio Linfático , Vasos Linfáticos/patología , Masculino , Persona de Mediana Edad , Análisis Multivariante , Invasividad Neoplásica , Estadificación de Neoplasias , Neoplasias Peritoneales/secundario , Modelos de Riesgos Proporcionales , Medición de Riesgo , Membrana Serosa/patología , Neoplasias Gástricas/terapia , Carga Tumoral
12.
J Photochem Photobiol B ; 173: 538-544, 2017 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-28692925

RESUMEN

BACKGROUND: To evaluate for the first time in vivo the effects of methylene blue (MB) photosensitizer dissolved in ethanol in antimicrobial photodynamic therapy (aPDT) as adjuvant periodontal treatment, at plasmatic oxidative stress and vascular behavior in rat model. METHODS: Wistar rats were divided into negative control (NC, no periodontitis) and positive control (PC, with periodontitis, without any treatment). The other groups had periodontitis and were treated with scaling and root planing (SRP); SRP+aPDT+MB dissolved in water (aPDT I); SRP+aPDT+MB dissolved in ethanol (aPDT II). The periodontitis was induced by ligature at the mandibular right first molar. At 7/15/30days, rats were euthanized, the plasma was used to determine oxidative stress parameters and gingival tissue for histomorphometric analysis. RESULTS: PC showed higher thiobarbituric acid reactive substances levels in 7/15/30days. aPDT II was able to block the lipid peroxidation, especially between 15th and 30th days. Glutathione reduced levels were consumed in PC, aPDT I and II groups throughout the experiment. aPDT II increased the vitamin C levels which were restored in this group in the 30th day. aPDT II group showed the highest number of blood vessels. CONCLUSION: In summary, the aPDT with MB dissolved in ethanol provides better therapeutic responses in periodontitis treatment.


Asunto(s)
Antiinfecciosos/farmacología , Azul de Metileno/farmacología , Estrés Oxidativo/efectos de los fármacos , Fármacos Fotosensibilizantes/farmacología , Animales , Antiinfecciosos/uso terapéutico , Ácido Ascórbico/sangre , Vasos Sanguíneos/efectos de los fármacos , Vasos Sanguíneos/patología , Vasos Sanguíneos/efectos de la radiación , Raspado Dental , Encía/patología , Encía/efectos de la radiación , Glutatión/sangre , Luz , Masculino , Azul de Metileno/uso terapéutico , Estrés Oxidativo/efectos de la radiación , Periodontitis/tratamiento farmacológico , Periodontitis/radioterapia , Fotoquimioterapia , Fármacos Fotosensibilizantes/uso terapéutico , Ratas , Ratas Wistar , Aplanamiento de la Raíz
13.
J Cosmet Laser Ther ; 19(7): 397-403, 2017 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-28622041

RESUMEN

BACKGROUND: The aim of the present study was to evaluate the effects of low-level laser therapy (LLLT) on the healing of bone defects in rats with streptozotocin (STZ)-induced DM. METHODS: 28 male Sprague-Dawley rats were used in this study. 14 animals received a single dose of STZ intraperitoneally (65 mg/kg) to induce Type I DM, whereas others were injected only with sterile saline solution. Four weeks later, standard bone defects were created in the tibiae of rats. Surgical wounds in one group from each of the diabetic and non-diabetic animals were irradiated with diode laser for every other day for 4 weeks and they were described as DM + LLLT and CONT + LLLT groups, respectively. Remaining two groups received no laser treatment. New bone formation, osteoblast and blood vessel counts were calculated in histologic sections. RESULTS: DM group had significantly smaller bone area and lower blood vessel count when compared to DM + LLLT, CONT and CONT + LLLT groups (p < 0.05 for each). CONT and CONT + LLLT groups had significantly larger bone area than DM + LLLT group (p < 0.05 for both). CONCLUSIONS: LLLT application promoted vascularization and new bone formation in animals with DM to a limited extent, since it was unable to support the healing process up to the level of non-diabetic animals.


Asunto(s)
Diabetes Mellitus Experimental/fisiopatología , Diabetes Mellitus Tipo 1/fisiopatología , Láseres de Semiconductores/uso terapéutico , Terapia por Luz de Baja Intensidad , Osteogénesis/efectos de la radiación , Tibia/patología , Animales , Vasos Sanguíneos/patología , Recuento de Células , Diabetes Mellitus Experimental/inducido químicamente , Diabetes Mellitus Tipo 1/inducido químicamente , Masculino , Neovascularización Fisiológica/efectos de la radiación , Osteoblastos/efectos de la radiación , Ratas Sprague-Dawley , Estreptozocina , Tibia/lesiones , Tibia/efectos de la radiación , Cicatrización de Heridas/efectos de la radiación
14.
Tumour Biol ; 39(6): 1010428317705758, 2017 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-28618962

RESUMEN

For tumor to grow beyond 1-2 mm3 size, tumor recruits new blood vessels referred as angiogenesis; therefore, targeting angiogenesis can be a promising strategy to suppress cancer progression. In this study, in order to develop a good angiogenesis model, we investigated effect of Dalton's lymphoma on angiogenesis and further monitored the role of melatonin on regulation of angiogenesis. To evaluate angiogenesis, endothelial cells were isolated from main thoracic aorta and cultured in vitro in the presence or absence of Dalton's lymphoma supplemented with or without melatonin to monitor their role on its proliferation and migration, a hallmark of angiogenesis. Chick chorioallantoic membrane as well as mice mesentery which allows in vivo studies of tumor angiogenesis and testing of anti-angiogenic molecules was used to validate the in vitro analysis. To further extend our understanding about the regulation of the angiogenesis, we evaluated expression of tissue inhibitor of metalloproteinases 3, vascular endothelial growth factor, vascular endothelial growth factor receptor, and fibroblast growth factor in Dalton's lymphoma cells and mesentery by semiquantitative and quantitative reverse transcription polymerase chain reaction analysis. Dalton's lymphoma ascites induced significant increase in endothelial cell proliferation, migration, and sprouting of the tertiary branching in chorioallantoic membrane and mesentery of Dalton's lymphoma-bearing mice, whereas melatonin treatment led to their inhibition in a dose-dependent manner. Semiquantitative and quantitative reverse transcription polymerase chain reaction analysis of melatonin-treated Dalton's lymphoma cells and mesentery tissue clearly demonstrated restoration of angiogenesis-related genes tissue inhibitor of metalloproteinases 3 and reduction of vascular endothelial growth factor, vascular endothelial growth factor receptor, and fibroblast growth factor messenger RNA expression. Taken together, our results strongly demonstrate that Dalton's lymphoma provides pro-angiogenic environment leading to significant increase in angiogenesis, and further melatonin treatment reduced the Dalton's lymphoma ascites-induced angiogenesis implying that Dalton's lymphoma can serve as a very good model to study angiogenesis as well as for screening of drugs that can target angiogenesis.


Asunto(s)
Movimiento Celular/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Linfoma/tratamiento farmacológico , Neovascularización Patológica/tratamiento farmacológico , Animales , Vasos Sanguíneos/efectos de los fármacos , Vasos Sanguíneos/patología , Carcinogénesis/efectos de los fármacos , Modelos Animales de Enfermedad , Células Endoteliales/patología , Regulación Neoplásica de la Expresión Génica/efectos de los fármacos , Humanos , Linfoma/genética , Linfoma/patología , Melatonina/administración & dosificación , Ratones , Proteínas de Neoplasias/genética , Neovascularización Patológica/genética , Neovascularización Patológica/patología , Técnicas de Cultivo de Órganos , ARN Mensajero/genética , Ensayos Antitumor por Modelo de Xenoinjerto
15.
Angiogenesis ; 20(4): 409-426, 2017 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-28660302

RESUMEN

Tumor blood vessels are a key target for cancer therapeutic management. Tumor cells secrete high levels of pro-angiogenic factors which contribute to the creation of an abnormal vascular network characterized by disorganized, immature and permeable blood vessels, resulting in poorly perfused tumors. The hypoxic microenvironment created by impaired tumor perfusion can promote the selection of more invasive and aggressive tumor cells and can also impede the tumor-killing action of immune cells. Furthermore, abnormal tumor perfusion also reduces the diffusion of chemotherapeutic drugs and radiotherapy efficiency. To fight against this defective phenotype, the normalization of the tumor vasculature has emerged as a new therapeutic strategy. Vascular normalization, by restoring proper tumor perfusion and oxygenation, could limit tumor cell invasiveness and improve the effectiveness of anticancer treatments. In this review, we investigate the mechanisms involved in tumor angiogenesis and describe strategies used to achieve vascular normalization.


Asunto(s)
Inhibidores de la Angiogénesis/uso terapéutico , Terapia Molecular Dirigida , Neoplasias/irrigación sanguínea , Neoplasias/tratamiento farmacológico , Neovascularización Patológica/tratamiento farmacológico , Animales , Vasos Sanguíneos/patología , Humanos , Factor A de Crecimiento Endotelial Vascular/antagonistas & inhibidores , Factor A de Crecimiento Endotelial Vascular/metabolismo
16.
Dis Model Mech ; 10(3): 337-348, 2017 03 01.
Artículo en Inglés | MEDLINE | ID: mdl-28153846

RESUMEN

Hemorrhagic stroke accounts for 10-15% of all strokes and is strongly associated with mortality and morbidity worldwide, but its prevention and therapeutic interventions remain a major challenge. Here, we report the identification of miconazole as a hemorrhagic suppressor by a small-molecule screen in zebrafish. We found that a hypomorphic mutant fn40a, one of several known ß-pix mutant alleles in zebrafish, had the major symptoms of brain hemorrhage, vessel rupture and inflammation as those in hemorrhagic stroke patients. A small-molecule screen with mutant embryos identified the anti-fungal drug miconazole as a potent hemorrhagic suppressor. Miconazole inhibited both brain hemorrhages in zebrafish and mesenteric hemorrhages in rats by decreasing matrix metalloproteinase 9 (MMP9)-dependent vessel rupture. Mechanistically, miconazole downregulated the levels of pErk and Mmp9 to protect vascular integrity in fn40a mutants. Therefore, our findings demonstrate that miconazole protects blood vessels from hemorrhages by downregulating the pERK-MMP9 axis from zebrafish to mammals and shed light on the potential of phenotype-based screens in zebrafish for the discovery of new drug candidates and chemical probes for hemorrhagic stroke.


Asunto(s)
Hemorragia Cerebral/enzimología , Hemorragia Cerebral/prevención & control , Metaloproteinasa 9 de la Matriz/metabolismo , Miconazol/uso terapéutico , Animales , Vasos Sanguíneos/patología , Vasos Sanguíneos/ultraestructura , Hemorragia Cerebral/tratamiento farmacológico , Hemorragia Cerebral/patología , Modelos Animales de Enfermedad , Evaluación Preclínica de Medicamentos , Matriz Extracelular/efectos de los fármacos , Matriz Extracelular/metabolismo , Sistema de Señalización de MAP Quinasas/efectos de los fármacos , Miconazol/farmacología , Mutación/genética , Rotura , Accidente Cerebrovascular/complicaciones , Accidente Cerebrovascular/tratamiento farmacológico , Accidente Cerebrovascular/patología , Activador de Plasminógeno de Tipo Uroquinasa/metabolismo , Pez Cebra
17.
Clin Cancer Res ; 23(15): 4482-4492, 2017 Aug 01.
Artículo en Inglés | MEDLINE | ID: mdl-28223275

RESUMEN

Purpose: C-X-C chemokine receptor type 4 (CXCR4) is known to be involved in both developmental and adult angiogenesis; however, its role in tumor angiogenesis remains largely unknown. Here, the role of vascular CXCR4 in regulating vascular structure in hepatocellular carcinoma (HCC) was assessd, and the clinical value of CXCR4 was explored.Experimental Design: The expression of CXCR4 in HCC was determined by IHC and immunofluorescence. Characteristics of CXCR4+ cells were determined by in vitro and mice experiments. Kaplan-Meier survival analysis was used to determine the correlation of CXCR4 expression with prognosis.Results: We found that CXCR4 is selectively expressed on a fraction of tumor endothelial cells (TECs) in HCC tissues, but not on the hepatic endothelium in peritumoral area. High levels of CXCR4 on TECs tended to develop a sinusoidal vasculature in tumors and predicted poor prognosis for patients with HCC. CXCR4+ endothelial cells (EC) displayed the functional features of tip cells, with increased expression of tip cell-related markers. Functional studies revealed that CXCR4 could directly promote vessel sprouting in vitro and in vivo Interestingly, sorafenib treatment reduced the frequency of CXCR4+ ECs in culture and inhibited the formation of sinusoidal vasculature and growth of CXCR4High xenograft tumors. Moreover, high CXCR4 vascular density in resected tumor tissues before sorafenib treatment was associated with prolonged survival in patients with advanced HCC treated with sorafenib.Conclusions: These data revealed that CXCR4 is a novel HCC vascular marker for vessel sprouting and could serve as a potential therapeutic target and a predictive factor for sorafenib treatment in patients with HCC. Clin Cancer Res; 23(15); 4482-92. ©2017 AACR.


Asunto(s)
Carcinoma Hepatocelular/tratamiento farmacológico , Neoplasias Hepáticas/tratamiento farmacológico , Niacinamida/análogos & derivados , Compuestos de Fenilurea/administración & dosificación , Receptores CXCR4/genética , Adulto , Anciano , Animales , Biomarcadores de Tumor , Vasos Sanguíneos/efectos de los fármacos , Vasos Sanguíneos/patología , Carcinoma Hepatocelular/genética , Carcinoma Hepatocelular/patología , Línea Celular Tumoral , Supervivencia sin Enfermedad , Femenino , Regulación Neoplásica de la Expresión Génica/efectos de los fármacos , Humanos , Estimación de Kaplan-Meier , Hígado/efectos de los fármacos , Hígado/patología , Neoplasias Hepáticas/genética , Neoplasias Hepáticas/patología , Masculino , Ratones , Persona de Mediana Edad , Niacinamida/administración & dosificación , Niacinamida/efectos adversos , Niacinamida/genética , Compuestos de Fenilurea/efectos adversos , Pronóstico , Transducción de Señal/efectos de los fármacos , Sorafenib , Ensayos Antitumor por Modelo de Xenoinjerto
18.
Ann Surg Oncol ; 24(4): 1077-1084, 2017 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-27624582

RESUMEN

BACKGROUND: Perineural invasion (PNI) in colon cancer (CC) has been associated with poorer prognosis even in stage II disease (T3-4 N0 M0). The aim of this study is to analyze prognostic histopathologic factors in stage II colon cancer in patients treated with curative surgery as established in National Comprehensive Cancer Network guidelines. METHODS: From a prospective database of CC cases, 507 patients with stage I-II disease who had undergone curative resection from January 2000 and December 2012 were identified. Of these patients, 17 % received 5-flurouracil-based adjuvant chemotherapy. Together with demographic and anatomic variables, we also studied perineural and lymphovascular invasion, degree of differentiation, and their correlation with disease-free survival. RESULTS: Perineural invasion was identified in 57 patients (11.2 %) and lymphovascular invasion (LVI) in 82 (16.2 %) of the 507 patients. Perineural invasion was associated with LVI, the depth of invasion of the wall of the colon, and location of the tumor. Overall and disease-free survival of the complete series at 5 and 10 years was 89.5, 85.2, 83.2 and 81.6 %, respectively. In the PNI positive patients, disease-free survival at 5 years was significantly lower than in those without PNI (73.5 vs 88.6 %; p = 0.02). Multivariate analysis showed the presence of PNI to be a significant independent prognostic factor for disease-free survival (p = 0.025). Adjuvant chemotherapy reversed the impact of PNI on 5- to 10-year disease-free survival. CONCLUSIONS: PNI a major prognostic and predictive factor in stage II colon cancer, and our results support the use of adjuvant chemotherapy in patients with PNI.


Asunto(s)
Adenocarcinoma/tratamiento farmacológico , Adenocarcinoma/patología , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Neoplasias del Colon/tratamiento farmacológico , Neoplasias del Colon/patología , Nervios Periféricos/patología , Adenocarcinoma/cirugía , Anciano , Vasos Sanguíneos/patología , Quimioterapia Adyuvante , Neoplasias del Colon/cirugía , Supervivencia sin Enfermedad , Femenino , Fluorouracilo/administración & dosificación , Humanos , Vasos Linfáticos/patología , Masculino , Persona de Mediana Edad , Clasificación del Tumor , Invasividad Neoplásica , Estadificación de Neoplasias , Compuestos Organoplatinos/administración & dosificación , Oxaliplatino , Estudios Retrospectivos , Tasa de Supervivencia
19.
Nutr Metab Cardiovasc Dis ; 27(3): 191-200, 2017 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-27692558

RESUMEN

AIMS: To overview the effects of omega-3 polyunsaturated fatty acids (PUFA) on blood vessels and blood pressure (BP) and their relevance for cardiovascular prevention. DATA SYNTHESIS: The importance of omega-3 PUFA for the cardiovascular system has come under the spotlight during the last decades. These fatty acids are present in variable amounts in cell membranes of mammal species, and their content affects a variety of cellular functions. Evidence obtained in animal and human studies suggests that omega-3 PUFA affect many steps of the atherosclerotic process. In blood vessels, omega-3 PUFA improve endothelial function; promote vasodilatation through relaxation of smooth muscle cells; exert antioxidant, anti-inflammatory, and antithrombotic actions; delay development of plaques and increase their stability; and decrease wall stiffening. Omega-3 PUFA might affect BP, and studies conducted with ambulatory monitoring suggest that supplementation with these fatty acids decreases the average 24-h BP levels. This effect on BP is related to the pretreatment membrane content of omega-3 PUFA, and this might explain some inconsistencies among intervention trials. Meta-analyses indicate that omega-3 PUFA have a mild but significant BP lowering effect. While encouraging results were initially obtained with the use of omega-3 PUFA supplements in secondary prevention trials, meta-analyses have not confirmed the ability of these fatty acids to decrease the risk of coronary heart and cerebrovascular disease. CONCLUSIONS: Omega-3 PUFA are associated with significant improvement in vascular function and lowering of BP. However, the evidence currently supporting the role of these fatty acids in cardiovascular prevention is weak and needs further investigation.


Asunto(s)
Aterosclerosis/prevención & control , Presión Sanguínea/efectos de los fármacos , Vasos Sanguíneos/efectos de los fármacos , Ácidos Grasos Omega-3/administración & dosificación , Hipertensión/prevención & control , Rigidez Vascular/efectos de los fármacos , Aterosclerosis/diagnóstico , Aterosclerosis/etiología , Aterosclerosis/fisiopatología , Vasos Sanguíneos/patología , Vasos Sanguíneos/fisiopatología , Medicina Basada en la Evidencia , Humanos , Hipertensión/diagnóstico , Hipertensión/etiología , Hipertensión/fisiopatología , Placa Aterosclerótica , Factores Protectores , Factores de Riesgo , Resultado del Tratamiento
20.
J Appl Oral Sci ; 24(5): 423-430, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-27812611

RESUMEN

OBJECTIVE:: To investigate the effect of HRE (Hippophae rhamnoides extract) on oral mucositis induced in rats with MTX. MATERIAL AND METHODS:: Experimental animals were divided into groups as healthy (HG), HRE+MTX (HMTX), and control group, which received MTX (MTXC). HMTX group received 50 mg/kg HRE while MTXC and HG groups received equivolume distilled water with gavage once a day. After one hour of HRE and distilled water administration, HMTX and MTXC groups received a single dose of oral MTX 5 mg/ kg. This procedure was repeated for one month. RESULTS:: The levels of MDA, IL-1ß, and TNF-α were found to be significantly higher in the cheek, lower lip, and tongue tissue of the animals receiving MTX, compared with HG and HMTX groups; however, these parameters were lower in the cheek and low lip tissue, and a milder damage ocurred in these tissues, compared with the tongue tissue in MTXC group. No histopathologic damage was observed in the cheek, lower lip, and tongue tissues of the rats treated with HRE. CONCLUSION:: This findings indicate that HRE as a natural product is an important advantage compared with synthetic drugs for prophylaxis of oral mucositis developed due to MTX.


Asunto(s)
Antagonistas del Ácido Fólico/efectos adversos , Hippophae/química , Metotrexato/efectos adversos , Extractos Vegetales/farmacología , Estomatitis/inducido químicamente , Estomatitis/tratamiento farmacológico , Animales , Vasos Sanguíneos/patología , Mejilla/patología , Expresión Génica , Interleucina-1beta/análisis , Interleucina-1beta/efectos de los fármacos , Labio/patología , Malondialdehído/análisis , Extractos Vegetales/uso terapéutico , Ratas , Reproducibilidad de los Resultados , Estomatitis/patología , Lengua/patología , Resultado del Tratamiento , Factor de Necrosis Tumoral alfa/análisis , Factor de Necrosis Tumoral alfa/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA